Zoono Group Limited

ZNO

AU000000ZNO4

Personal Products

Market Closed - Australian S.E. Other stock markets 07:10:51 20/05/2024 BST			5-day change	1st Jan Change
0.029 ^AUD	+7.41%		+7.41%	-34.09%

05-17	Zoono Group Places Additional Shares to OSY Group	MT
05-08	Zoono Group Raises Maximum Amount Under the Rights Issue; Shares Jump 7%	MT

Zoono Group Limited Announces Cessation of Glenn Tetley as Director

May 05, 2017 at 07:38 am

Zoono Group Limited announced cessation of Glenn Tetley as director on 26 April 2017.

Latest news about Zoono Group Limited

Zoono Group Places Additional Shares to OSY Group	05-17	MT
Zoono Group Raises Maximum Amount Under the Rights Issue; Shares Jump 7%	05-08	MT
Zoono Group's Exclusive Agent OSY Signs First Major UK Client; Shares Up 18%	04-23	MT
Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue	03-26	MT
Zoono Group Says Unaware of Any Information for Share Price Fluctuation	03-19	MT
Zoono Group Signs Exclusive Deal for Sale Promotion for Products; Shares Up 8%	03-06	MT
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-21	CI
Zoono Group Delays Start of Up to AU$2.7 Million Rights Issue	01-31	MT
Zoono Group Faces Charges from the New Zealand Commerce Commission	12-21	MT
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23/08/23	CI
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23	CI
Zoono Group Limited Announces Change of Registered Address	01/11/22	CI
Zoono Group Limited Enters into Co-Development and Licence Agreement with Douglas Pharmaceuticals	17/10/22	CI
Zoono Group Limited Develops New Nasal Spray Product	17/10/22	CI
Zoono Group Limited Reports Earnings Results for the Full Year Ended June 30, 2022	25/08/22	CI
Zoono Group Appoints CEO	01/04/22	MT
Zoono Group Limited Appoints Barry Woolcott as Group Chief Executive Officer	01/04/22	CI
Zoono Group Limited Enters into Two New Exclusive Distribution Agreements with Star Pharma Distributora de Medicamentos e Correlatos LTDA	01/04/22	CI
Zoono Group Limited(ASX:ZNO) dropped from S&P/ASX All Ordinaries Index	21/03/22	CI
Zoono Group Limited Reports Earnings Results for the Half Year Ended December 31, 2021	23/02/22	CI
Zoono Signs Chinese Distribution Deal for Antimicrobial Product	01/02/22	MT
Zoono Group Limited Signs Distribution Agreement with China Animal Husbandry Group	31/01/22	CI
Apiam Animal Health's Distributor Gets US Regulatory Nod to Market Antimicrobial Technology	16/11/21	MT
Zoono Group Limited(ASX:ZNO) dropped from S&P/ASX Emerging Companies Index	20/09/21	CI
Zoono Group Limited(ASX:ZNO) dropped from S&P Global BMI Index	20/09/21	CI

Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries. The Company produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.

Sector

Personal Products

Calendar

21/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Personal Products

	1st Jan change	Capi.
ZOONO GROUP LIMITED	-34.09%	3.86M
PROCTER & GAMBLE COMPANY	+14.40%	396B
UNILEVER PLC	+12.95%	143B
COLGATE-PALMOLIVE COMPANY	+18.09%	77.23B
HINDUSTAN UNILEVER LIMITED	-12.61%	65.65B
ESTEE LAUDER	-7.86%	48.32B
KENVUE INC.	-4.92%	39.2B
BEIERSDORF	+6.96%	35.21B
ESSITY AB	+11.64%	18.31B
GODREJ CONSUMER PRODUCTS LIMITED	+14.87%	15.95B